JP5801809B2 - 急性腎損傷の診断および／または予後方法 - Google Patents

急性腎損傷の診断および／または予後方法 Download PDF

Info

Publication number
JP5801809B2
JP5801809B2 JP2012527360A JP2012527360A JP5801809B2 JP 5801809 B2 JP5801809 B2 JP 5801809B2 JP 2012527360 A JP2012527360 A JP 2012527360A JP 2012527360 A JP2012527360 A JP 2012527360A JP 5801809 B2 JP5801809 B2 JP 5801809B2
Authority
JP
Japan
Prior art keywords
mir
expression
kidney injury
acute kidney
microrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012527360A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013503617A5 (enExample
JP2013503617A (ja
Inventor
マリア・ラウラ・ガルシア・ベルメホ
エリア・アグアド・フライレ
フェルナンド・リアーニョ・ガルシア
ダビド・サエンス・モラレス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital Universitario Ramón y Cajal
Original Assignee
Hospital Universitario Ramón y Cajal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital Universitario Ramón y Cajal filed Critical Hospital Universitario Ramón y Cajal
Publication of JP2013503617A publication Critical patent/JP2013503617A/ja
Publication of JP2013503617A5 publication Critical patent/JP2013503617A5/ja
Application granted granted Critical
Publication of JP5801809B2 publication Critical patent/JP5801809B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2012527360A 2009-09-04 2010-09-03 急性腎損傷の診断および／または予後方法 Expired - Fee Related JP5801809B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200901825 2009-09-04
ES200901825A ES2363661B2 (es) 2009-09-04 2009-09-04 Método para el diagnóstico y/o pronóstico de daño renal agudo.
PCT/ES2010/070579 WO2011027019A2 (es) 2009-09-04 2010-09-03 Metodo para el diagnostico y/o pronostico de daño renal agudo

Publications (3)

Publication Number Publication Date
JP2013503617A JP2013503617A (ja) 2013-02-04
JP2013503617A5 JP2013503617A5 (enExample) 2013-10-10
JP5801809B2 true JP5801809B2 (ja) 2015-10-28

Family

ID=43649710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012527360A Expired - Fee Related JP5801809B2 (ja) 2009-09-04 2010-09-03 急性腎損傷の診断および／または予後方法

Country Status (12)

Country Link
US (1) US20120172248A1 (enExample)
EP (2) EP2474622A4 (enExample)
JP (1) JP5801809B2 (enExample)
CN (1) CN102575294B (enExample)
AU (1) AU2010291137A1 (enExample)
CA (1) CA2773054A1 (enExample)
ES (2) ES2363661B2 (enExample)
IN (1) IN2012DN01910A (enExample)
MX (1) MX2012002333A (enExample)
PT (1) PT3029156T (enExample)
RU (1) RU2629591C2 (enExample)
WO (1) WO2011027019A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2484779A1 (en) * 2011-02-03 2012-08-08 Medizinische Hochschule Hannover Device and method for analysis of kidney failure
ES2432853B1 (es) * 2011-12-15 2015-03-09 Fundación Para La Investigación Biomédica Del Hospital Universitario Ramón Y Cajal Metodo para el diagnostico y/o pronostico de dano renal agudo
RU2587012C1 (ru) * 2014-10-31 2016-06-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ульяновский государственный университет" Способ прогнозирования острого повреждения почек у больных острым коронарным синдромом
RU2583950C1 (ru) * 2015-05-13 2016-05-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ прогнозирования развития острого повреждения почки в условиях тепловой ишемии в эксперименте в зависимости от возраста и пола животных
RU2639465C2 (ru) * 2016-02-24 2017-12-21 федеральное государственное бюджетное образовательное учреждение высшего образования "Ульяновский государственный университет" Способ прогнозирования острого повреждения почек у больных острым коронарным синдромом
WO2018033454A1 (en) * 2016-08-19 2018-02-22 Fundación Para La Investigación Biomédica Del Hospital Universitario Ramón Y Cajal Mir-127 agents for use in the treatment of renal fibrosis
WO2018065390A1 (en) 2016-10-04 2018-04-12 Vib Vzw Means and methods to treat inflammatory diseases
RU2666911C2 (ru) * 2016-11-24 2018-09-13 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт общей патологии и патофизиологии" (ФГБНУ "НИИОПП") Способ для прогнозирования метастазирования рака яичников на основе группы генов микроРНК
TWI646199B (zh) * 2017-10-23 2019-01-01 長庚醫療財團法人林口長庚紀念醫院 用於預測一帶有急性心肌梗塞的人類個體發展出急性腎損傷之風險的方法
RU2702023C1 (ru) * 2018-08-17 2019-10-04 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики острого повреждения почек после органосохраняющего хирургического лечения локализованного рака почки
EP3862438A4 (en) * 2018-10-04 2022-08-03 Jichi Medical University FOR ACUTE KIDNEY FAILURE SPECIFIC BIOMARKER, METHODS FOR DIAGNOSIS OF ACUTE KIDNEY FAILURE, TEST KIT FOR ACUTE KIDNEY FAILURE, ANIMAL TREATMENT PROCEDURES AND MEDICATION FOR ACUTE KIDNEY FAILURE
RU2703399C1 (ru) * 2018-11-02 2019-10-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт общей патологии и патофизиологии" (ФГБНУ "НИИОПП") Способ для диагностики рака яичников на основе группы генов микроРНК
RU2724017C1 (ru) * 2019-05-17 2020-06-18 федеральное государственное бюджетное образовательное учреждение высшего образования "Ульяновский государственный университет" Способ прогнозирования острого повреждения почек у больных острым коронарным синдромом с использованием шкалы риска
EP3929308A1 (en) 2020-06-23 2021-12-29 Heinrich-Heine-Universität Düsseldorf Diagnostic methods on renal recovery in individuals suffering from acute kidney injury and suitable biomarkers therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7575863B2 (en) * 2004-05-28 2009-08-18 Applied Biosystems, Llc Methods, compositions, and kits comprising linker probes for quantifying polynucleotides
RU2270605C1 (ru) * 2004-06-18 2006-02-27 Государственное учреждение научный центр здоровья детей РАМН (ГУ НЦЗД РАМН) Способ оценки жизнеспособности почечной паренхимы
WO2007013919A2 (en) * 2005-07-21 2007-02-01 The Johns Hopkins University Methods of detecting and treating acute kidney injury
US20110059537A1 (en) * 2007-09-20 2011-03-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Method for estimating risk of acute kidney injury

Also Published As

Publication number Publication date
AU2010291137A1 (en) 2012-03-15
CN102575294A (zh) 2012-07-11
PT3029156T (pt) 2019-02-11
MX2012002333A (es) 2012-06-12
EP2474622A1 (en) 2012-07-11
WO2011027019A3 (es) 2011-04-28
IN2012DN01910A (enExample) 2015-07-24
US20120172248A1 (en) 2012-07-05
JP2013503617A (ja) 2013-02-04
EP2474622A4 (en) 2013-03-06
EP3029156B1 (en) 2018-11-07
ES2363661A1 (es) 2011-08-11
EP3029156A3 (en) 2016-09-14
ES2710332T3 (es) 2019-04-24
EP3029156A2 (en) 2016-06-08
CN102575294B (zh) 2015-07-01
RU2012106742A (ru) 2013-10-10
WO2011027019A2 (es) 2011-03-10
CA2773054A1 (en) 2011-03-10
RU2629591C2 (ru) 2017-08-30
ES2363661B2 (es) 2012-05-30

Similar Documents

Publication Publication Date Title
JP2013503617A (ja) 急性腎損傷の診断および／または予後方法
Vahed et al. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients
CN107385035B (zh) 与2型糖尿病视网膜病变相关的血清/血浆miRNA标志物及其应用
CN108179194B (zh) 一种肿瘤分子标志物circBIRC6及其抑制剂和用途
CN104080925B (zh) 用于对急性肾损伤进行诊断和/或预后的方法
WO2020088704A1 (en) Postpartum epigenetic profile of cardiovascular micrornas in women exposed to pregnancy-related complications
CN107937512A (zh) 用于诊断复发性流产的血清microRNA标志物、引物组及应用和试剂盒
CN111154863B (zh) lncRNA在制备诊断和/或治疗骨关节炎的产品中的应用
CN107012256A (zh) 腹主动脉瘤诊治标志物
CN106676185B (zh) 一种预测个体动脉瘤发生的血液中外泌体miRNA谱及检测试剂盒
CN104962654B (zh) lncRNA-MALAT1在制备增生性玻璃体视网膜病变诊断试剂中的应用
Golabi et al. Prediction of transplant rejection using non-coding RNAs
CN116356009A (zh) 一种miR-122-5p的应用
EP3365463A1 (en) Biomarker for predicting coronary artery disease in smokers
CN113718028A (zh) 基于微小rna的子痫前期诊断用途及组合物
CN107012257A (zh) 用于诊治腹主动脉瘤的生物标志物
CN106939340A (zh) 一种与肺腺癌转移及预后相关的分子标记物及其应用
CN116254340B (zh) 胸主动脉瘤生物标记物及其应用
CN111235263B (zh) 诊治骨关节炎的靶基因
ES2374890B1 (es) Método para el diagnóstico y/o pronóstico de daño renal agudo.
Al-Talabani et al. Mastering noninvasive predictive biomarkers to follow up renal transplant patients
Sardari et al. The role of micro-RNA in heart failure
ES2381401A1 (es) Método para el diagnóstico y/o pronóstico de daño renal agudo.
ALSHAWADFI et al. MICRORNA UTILITY FOR DIAGNOSING ISCHEMIC STROKE IN EGYPTIAN PATIENTS
CN108588217A (zh) 一种LncRNA作为深静脉血栓形成诊断标志物的应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130820

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130820

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150605

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150804

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150827

R150 Certificate of patent or registration of utility model

Ref document number: 5801809

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees